SPECIAL DIGITAL SUPPLEMENT
SPONSORED CONTENT BY GUERBET
THE MAGAZINE OF DISTINCTION IN RADIOLOGY
WHY TWO IMAGING
CENTERS CHANGED THEIR
Why Two Imaging Centers Changed
Their Contrast Medium
IMPORTANT SAFETY INFORMATION1
WARNING: NEPHROGENIC SYSTEMIC FIBROSIS (NSF)
Gadolinium-based contrast agents (GBCAs) increase the risk for NSF among patients with impaired elimination of the drugs. Avoid use of
GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities.
NSF may result in fatal or debilitating ﬁbrosis aﬀecting the skin, muscle and internal organs.
· The risk for NSF appears highest among patients with:
o Chronic, severe kidney disease (GFR < 30 mL/min/1.73m2), or
o Acute kidney injury.
· Screen patients f
SPECIAL DIGITAL SUPPLEMENT SPONSORED CONTENT BY G
Switching to Dotarem® Why Two Imaging Centers Cha
Interview with Ryan Garland, MHA, BS, RT (R), Sys
Interview with Mark L. Winkler, MD, President of
IMPORTANT SAFETY INFORMATION CONT.1 Indication
MRI Interconnected Solutions CONTRAST AGENT I